Home » Topics » BioWorld Science

BioWorld Science
RSS

Symphogen initiates first-in-human study of Sym-022 in advanced solid tumors or lymphomas

May 2, 2018

MEN-1611 demonstrates promising in vivo activity in various cancer models

May 2, 2018

Shire offers overview of first quarter 2018

May 2, 2018

Kodiak Sciences describes KSI-301, an anti-VEGF therapy with extended half-life

May 2, 2018

MedImmune presents novel bivalent bispecific antibody MEDI-1109

May 2, 2018

Starpharma completes rolling NDA submission for VivaGel BV

May 2, 2018

GlaxoSmithKline reflects on accomplishments of first quarter 2018

May 2, 2018

Crescendo Biologics completes Series B financing

May 2, 2018

Novel PD-1/GITRL bispecific fusion proteins demonstrate antitumor activity in vivo

May 2, 2018

Trogarzo becomes available in the U.S.

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...